Viking Therapeutics faces pressure after mixed oral obesity pill trial results, raising safety concerns but still meeting key ...

The struggling Danish company says it looks to reorganize, with the impact on North Carolina workers still unclear.

Novo Nordisk, facing competition in the obesity drug market, has instructed employees to return to the office to enhance ...

Novo Nordisk has mandated a return to office work for all staff to speed up decision-making and improve market execution, ...

Consumer prices rose 2.9% in August from a year earlier, the Labor Department said Tuesday, the biggest increase since ...

This Denmark-headquartered company underestimated demand for its anti-obesity treatment Wegovy when it launched in the U.S.

FRANKFURT, Germany (AP) — Danish pharmaceutical company Novo Nordisk, maker of weight-loss drug Wegovy, said Wednesday it ...

The company downgraded its guidance for the second time in six weeks as it announced a restructuring plan.

Stocks have been hitting records in large part because Wall Street is expecting the economy to pull off a delicate balancing ...

The Institute for Clinical and Economic Review (ICER) on Tuesday released a Draft Evidence Report assessing the comparative ...

The explosive rise of GLP-1 medications—such as Mounjaro, Ozempic, and Wegovy—has ignited more than just headlines. It has fundamentally shifted how Americans access and pay for medications, driving ...